We design, produce, control and ensure the quality of our biopharmaceutical products and vaccines for the Cuban health system and for export to other countries. Our core business is the manufacture of active pharmaceutical ingredients (APIs) for the manufacture of vaccines, interferons and growth factors. We obtain antibodies that are used in the elaboration of diagnostic means and products for the treatment and improvement of animals and agricultural crops. We also take care of the activities of packaging and conditioning of finished products, and we participate in the transfer of technologies and incorporate new products from the research and development areas. For all this, we have production facilities, designed in accordance with current pharmaceutical industry standards and in harmony with international regulations on good manufacturing practices.
Our line of pharmaceutical productions, with principles of synthetic proteins and peptides, is used in the preparation of preventive vaccines for hepatitis B and influenza (flu); in the production of thrombolytics; in obtaining recombinant human epidermal growth factor with healing activity (in injectable and topical formulation) for the treatment of diabetic foot ulcers and burns; as well as in the manufacture of alpha and gamma interferons (formulated individually or in combination) for the treatment of hepatitis, cancers, rheumatoid arthritis and COVID-19. We also produce blood products, such as transfer factor, with immunological activity.